Style | Citing Format |
---|---|
MLA | Mosavi SS, et al.. "Therapeutic Effects of Resveratrol and Omega-3 in Mice Atherosclerosis: Focus on Histopathological Changes." BMC Complementary Medicine and Therapies, vol. 23, no. 1, 2023, pp. -. |
APA | Mosavi SS, Rabizadeh S, Yadegar A, Seifouri S, Mohammadi F, Qahremani R, Salehi SS, Rajab A, Esteghamati A, Nakhjavani M (2023). Therapeutic Effects of Resveratrol and Omega-3 in Mice Atherosclerosis: Focus on Histopathological Changes. BMC Complementary Medicine and Therapies, 23(1), -. |
Chicago | Mosavi SS, Rabizadeh S, Yadegar A, Seifouri S, Mohammadi F, Qahremani R, Salehi SS, Rajab A, Esteghamati A, Nakhjavani M. "Therapeutic Effects of Resveratrol and Omega-3 in Mice Atherosclerosis: Focus on Histopathological Changes." BMC Complementary Medicine and Therapies 23, no. 1 (2023): -. |
Harvard | Mosavi SS et al. (2023) 'Therapeutic Effects of Resveratrol and Omega-3 in Mice Atherosclerosis: Focus on Histopathological Changes', BMC Complementary Medicine and Therapies, 23(1), pp. -. |
Vancouver | Mosavi SS, Rabizadeh S, Yadegar A, Seifouri S, Mohammadi F, Qahremani R, et al.. Therapeutic Effects of Resveratrol and Omega-3 in Mice Atherosclerosis: Focus on Histopathological Changes. BMC Complementary Medicine and Therapies. 2023;23(1):-. |
BibTex | @article{ author = {Mosavi SS and Rabizadeh S and Yadegar A and Seifouri S and Mohammadi F and Qahremani R and Salehi SS and Rajab A and Esteghamati A and Nakhjavani M}, title = {Therapeutic Effects of Resveratrol and Omega-3 in Mice Atherosclerosis: Focus on Histopathological Changes}, journal = {BMC Complementary Medicine and Therapies}, volume = {23}, number = {1}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Mosavi SS AU - Rabizadeh S AU - Yadegar A AU - Seifouri S AU - Mohammadi F AU - Qahremani R AU - Salehi SS AU - Rajab A AU - Esteghamati A AU - Nakhjavani M TI - Therapeutic Effects of Resveratrol and Omega-3 in Mice Atherosclerosis: Focus on Histopathological Changes JO - BMC Complementary Medicine and Therapies VL - 23 IS - 1 SP - EP - PY - 2023 ER - |